Suncoast Clinical Research is currently seeking participants who are 18 years or older and suffer from chronic kidney disease and high blood pressure for a research study.
Suncoast Clinical Research is currently seeking participants who are 18 years or older and suffer from chronic kidney disease and high blood pressure for a research study.
The purpose of this study is to determine the efficacy of baxdrostat in combination with dapagliflozin compared to dapagliflozin alone on chronic kidney disease progression in participants with chronic kidney disease and high blood pressure. By combining these two medications, it is expected to provide additional benefits in reducing cardiovascular risk and slowing the progression of chronic kidney disease.
This study is approximately 25 months (about 2 years) long and includes about 15 visits to the office. Compensation will be available for your trial related time if you qualify.
*Please note, other qualifications apply